在COVID-19住院后发现遗传性血液染色体
1Ball Memorial Transitional Year Program, Indiana University School of Medicine, Muncie, IN, USA zackhall@iu.edu.
BMJ case reports
|September 12, 2023
概括
通过监测升的费里水平,COVID-19感染可以揭示未被诊断的遗传性血染色体 (HH). 通过COVID-19监测进行早期的HH诊断,可以及时进行骨切除术治疗,防止症状发作.
科学领域:
- 内部医学 内部医学
- 遗传学 遗传学 是一个
- 传染性疾病 传染性疾病
背景情况:
- 费里丁水平对于监测COVID-19和遗传性血色素变异 (HH) 中的疾病严重程度至关重要.
- 感染期间费里含量升高可能是急性阶段反应或铁过载的结果.
- 医生寻求可靠的标记物来预测COVID-19疾病的进展.
研究的目的:
- 报告一个COVID-19感染显示未被诊断的遗传性血红色素病的病例.
- 要突出费里丁监测在诊断高血压中所起的作用.
- 强调HH的早期干预.
主要方法:
- 一个中度COVID-19感染的患者的病例报告.
- 在感染期间和感染后监测极高的费里水平.
- 遗传性血红色素病的诊断工作.
主要成果:
- 这位患者呈现出无症状,未被诊断的遗传性血色素病.
- COVID-19 感染导致费里水平显著升高.
- 通过监测费里分辨率,证实了HH的诊断.
- 早期的瘤切除治疗是为H.H.开始的.
结论:
- 在COVID-19患者中,费里的监测可以揭示潜在的遗传性血色素变异症.
- 及时诊断和治疗HH对于预防疾病进展至关重要.
- 这一案例强调了在患有无法解释的高费里的患者中考虑铁过载障碍的重要性.
更多相关视频
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
2.8K
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.4K
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Disorders of Hemostasis
987
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
987
Disorders of Erythrocytes
974
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
974
Hemoglobin
3.7K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
3.7K
Single Nucleotide Polymorphisms-SNPs
15.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K
Diseases of the Liver and Gallbladder
621
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
621
